ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 107 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2024. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $775,399 | -56.7% | 59,784 | -41.7% | 0.00% | -66.7% |
Q1 2024 | $1,791,833 | +0.8% | 102,625 | -45.7% | 0.00% | 0.0% |
Q4 2023 | $1,776,871 | +39.9% | 188,828 | +66.1% | 0.00% | 0.0% |
Q3 2023 | $1,269,716 | +30.1% | 113,672 | +149.3% | 0.00% | -25.0% |
Q2 2023 | $975,754 | +54.1% | 45,596 | +191.3% | 0.00% | +33.3% |
Q1 2023 | $633,048 | -41.8% | 15,654 | -33.1% | 0.00% | -50.0% |
Q4 2022 | $1,088,382 | -39.5% | 23,396 | -32.6% | 0.01% | -45.5% |
Q3 2022 | $1,800,000 | +620.0% | 34,699 | +556.6% | 0.01% | +450.0% |
Q2 2022 | $250,000 | -62.2% | 5,285 | -43.2% | 0.00% | -66.7% |
Q1 2022 | $662,000 | +4.4% | 9,303 | +9.7% | 0.01% | +20.0% |
Q4 2021 | $634,000 | +26.8% | 8,479 | +4.7% | 0.01% | -68.8% |
Q4 2019 | $500,000 | – | 8,096 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 519,035 | $60,156,000 | 15.36% |
Matarin Capital Management, LLC | 201,703 | $23,377,378,000 | 1.69% |
ARMISTICE CAPITAL, LLC | 124,000 | $14,372,000 | 0.94% |
Sapphire Star Partners LP | 7,803 | $904,000 | 0.93% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 98,631 | $11,431,000 | 0.83% |
FARALLON CAPITAL MANAGEMENT LLC | 1,075,000 | $124,593,000 | 0.77% |
Granahan Investment Management | 100,670 | $11,668,000 | 0.70% |
Virtus ETF Advisers LLC | 6,577 | $762,000 | 0.67% |
AlphaMark Advisors, LLC | 11,115 | $1,288,000 | 0.52% |
Ativo Capital Management LLC | 15,029 | $1,742,000 | 0.48% |